Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder

NCT03206463 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03206463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Terminated
Start date
August 1, 2017
Completion date
September 29, 2017
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, delta-9-tetrahydroncannabinol, healthy controls